Clinical Trial Detail

NCT ID NCT00996892
Title Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

lung non-small cell carcinoma

colorectal cancer

endometrial carcinoma

Advanced Solid Tumor

pancreatic adenocarcinoma

Therapies

Cobimetinib + Pictilisib

Age Groups: adult senior

No variant requirements are available.